Baseline characteristics of enrollees in the National Heart, Lung and Blood Institute registry of α1-antitrypsin deficiency

Chest

Volumn 111, Issue 2, 1997, Pages 394-403

  McElvaney, Noel G ^a   Stoller, James K ^b   Buist, A Sonia ^c   Prakash, Udaya B S ^d   Brantly, Mark L ^a   Schluchter, Mark D ^b   Crystal, Ronald D ^e  

^a NATIONAL HEART LUNG AND BLOOD INSTITUTE   (United States)

^b LERNER RESEARCH INSTITUTE   (United States)

^c OREGON HEALTH AND SCIENCE UNIVERSITY   (United States)

^d MAYO CLINIC   (United States)

^e WEILL CORNELL MEDICAL CENTER   (United States)

Author keywords

augmentation therapy; COPD; emphysema; registries; 1 antitrypsin

Indexed keywords

ALPHA 1 ANTITRYPSIN;

ADULT; ALPHA 1 ANTITRYPSIN DEFICIENCY; ARTICLE; CIGARETTE SMOKING; FEMALE; HUMAN; LONGITUDINAL STUDY; LUNG EMPHYSEMA; MAJOR CLINICAL STUDY; MALE; PHENOTYPE; PRIORITY JOURNAL; PROSPECTIVE STUDY; REGISTER;

EID: 0031027927     PISSN: 00123692     EISSN: None     Source Type: Journal    
DOI: 10.1378/chest.111.2.394     Document Type: Article

References (31)

1. 1-Antitrypsin deficiency. In: Stansbury JB, Wyngaarden JB, Frederickson DS, et al, eds. The metabolic basis of inherited disease. 5th ed. New York: MeGraw-Hill, 1982; 1450-67
2. 1-Antitrypsin deficiency, emphysema, and liver disease: genetic basis and strategies for therapy. J Clin Invest 1990; 85:1343-52
3. 1-Antitrypsin deficiency. In: Scriver CR, Beaudet AL, Sly WS, et al. eds. The metabolic basis of inherited disease. 6th ed. New York: McGraw-Hill, 1989; 2409-37
4. 1-antitrypsin deficiency. Scand J Clin Lab Invest 1963; 15:132-40
5. 1-antitrypsin and the gene for the S variant. Biochemistry 1984; 23:4828-37
6. 1-antitrypsin gene and its deficiency states. Trends Genet 1989; 5:411-17
7. Perlmutter DH, May LT, Sehgal PB. Interferon b/interleukin 6 modulates synthesis of α 1-antitrypsin in human mononuclear phagocytes and in human hepatoma cells. J Clin Invest 1989; 84:144-48
8. Mornex JF, Chytil-Weir A, Martinet Y, et al. Expression of the alpha 1-antitrypsin gene in mononuclear phagocytes of normal and alpha 1-antitrypsin deficient individuals. J Clin Invest 1986; 77:1952-61
9. du Bois RM, Bernaudin J-F, Paako P, et al. Human neutrophils express the α 1-antitrypsin gene and produce α 1-antitrypsin. Blood 1992; 77:2724-30
10. Gadek JE, Fells GA, Zimmerman RL, et al. Antielastases of human alveolar structures: implications for protease-antiprotease theory of emphysema. J Clin Invest 1981; 68:889-98
11. 1-antitrypsin deficiency. Am J Med 1988; 84(suppl 6A):52-02
12. Travis J. Structure function, and control of neutrophil proteinases. Am J Med 1988; 84:37-42
13. Hubbard RC, Brantly M, Crystal RG. Proteases. In: Crystal RG, West JB, Barnes F, et al, eds. The lung. New York: Raven Press, 1991; 1763-74
14. 1-antitrypsin gene and its mutations: clinical consequences and strategies for therapy. Chest 1989; 95:196-208
15. Brantly ML, Paul LD, Miller BH, et al. Clinical features of the destructive lung disease associated with alpha-1-antitrypsin deficiency of adults with pulmonary symptoms. Am Rev Respir Dis 1988; 138:327-36
16. 1-antitrypsin phenotypes. Chest 1991; 100:703-08
17. Janoff A. Elastases and emphysema: current assessment of the protease-antiprotease hypothesis. Am Rev Respir Dis 1985; 132:417-33
18. Hubbard RC, Crystal RG. Susceptibility of the lung to proteolytic injury. In: Crystal RG, West JB, Barnes F, et al, eds. The lung. New York: Raven Press, 1991; 2059-72
19. Janoff A, Sloan B, Weinbaum G, et al. Experimental emphysema induced with purified human neutrophil elastase: tissue localization of the instilled protease. Am Rev Respir Dis 1977; 115:461-78
20. Senior RM, Tegner H, Kuhn C, et al. The induction of pulmonary emphysema with leukocyte elastase. Am Rev Respir Dis 1977; 116:469-75
21. Wewers MD, Casolaro MA, Sellers SE, et al. Replacement therapy for alpha-1-antitrypsin deficiency associated with emphysema. N Engl J Med 1987; 316:1055-62
22. Hubbard RC, Sellers S, Czerski D, et al. Biochemical efficacy and safety of monthly augmentation therapy for α1-antitrypsin deficiency. JAMA 1988; 260:1259-64
23. 1-antitrypsin. Chest 1994; 106:1223-32
24. American Thoracic Society. Standardization of spirometry-1987 update. Am Rev Respir Dis 1987; 136:1285-98
25. Crapo RO, Morris AM, Garduer RM. Reference spirometric values using techniques and equipment that meet the ATS recommendations. Am Rev Respir Dis 1981; 123;659-64
26. Crapo RO, Morris AM. Standardized single breath normal values for carbon monoxide diffusing capacity. Am Rev Respir Dis 1981; 123:185-89
27. Ferris BG. Epidemiology standardization project. Am Rev Respir Dis 1978; 118:1-113
28. Stoller JK, Smith P, Yang P, et al. Physical and social impact of alpha 1-antitrypsin deficiency: results of a survey. Cleve Clin J Med 1994; 61:461-67
29. Rodu B. An alternate approach to smoking control [editorial]. Am J Med Sci 1994; 308:32-4
30. Wall M, Moe E, Eisenberg J, et al. Long-term follow-up of a cohort of children with alpha 1-antitrypsin deficiency. J Pediatr 1990; 116:248-51
31. American Thoracic Society. Guidelines for the approach to the patient with severe hereditary alpha-1-antitrypsin. Am Rev Respir Dis 1989; 140:1494-97